Oxitone is a company specializing in AI-integrated data analytics and advanced FDA-cleared multi-parameter biosensors designed to address complex poly-chronic disease challenges at home. The company has developed the Oxitone 1000M, an ulnar bone pulse oximetry monitor, and offers Clinical Reporting as a Service (CRaaS) with a portfolio of disease-specific reports and indexes, as well as hyper-accurate personalized data analytics and intelligent decision-making support. Oxitone targets high-risk patients, seeking to enhance clinical outcomes for providers, develop effective care management strategies for payers, and collect and analyze hyper-personalized physiological effects of drugs for Pharma & CROs. The company's solutions aim to improve value-based healthcare by delivering extraordinary patient clinical and economical outcomes while reducing medical utilization and costs. Oxitone emphasizes the need for real-time data, continuous care flow, and the use of AI-powered predictive care to enable automated follow-up. The company's technology includes patented wrist ulna-bone multi-parameter medical biosensors and unique AI algorithms to automate patient follow-up. Oxitone provides a full end-to-end patient monitoring support system for conditions such as cardiopulmonary diseases, obstructive sleep apnea, and physiological stress, aiming to enable early identification and timely interventions.